School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Naval Medical University, Shanghai, China.
Pharm Biol. 2023 Dec;61(1):345-355. doi: 10.1080/13880209.2023.2173249.
CONTEXT: L (Rutaceae) (Au) and Blanco (Rutaceae) (Ci) are commonly used as couplet prokinetics and DC. (Umbelliferae) (Bup) is an herbal antidepressant in traditional Chinese medicine. OBJECTIVE: This study evaluates the synergistic prokinetic effects of Bup with Au and Ci in mice suffering from multistress-induced delayed gastric emptying (DGE). MATERIALS AND METHODS: Kunming mice were divided into four groups: control, DGE, AuCi and AuCiBup. Mice were gavaged with AuCi (14.25 g/kg) or AuCiBup (22.13 g/kg) extract for 12 days. Gastric reminder rate, intestinal driving ratio, sucrose preference and open field test were examined, and serotonin (5-HT), motilin (MTL), substance P (SP), 5-HTR and c-kit were assayed. Intracellular Ca levels in primary cultured gastric smooth muscle cells (GSMCs) were determined. RESULTS: Both AuCi and AuCiBup treatment significantly reduced gastric residual rate (39.5% and 67.7%, < 0.01). Higher serum levels of 5-HT, MTL and SP were observed in treatment groups (AuCi: 0.060 mg/L, AuCiBup: 0.089 mg/L, DGE: 0.025 mg/L, < 0.01). The expression of 5-HTR and c-kit in the antrum and duodenum was upregulated after treatment (AuCi and AuCiBup, 4.3-times, 2.8-times to DGE, < 0.01). Medicated serums of AuCi and AuCiBup effectively increased the influx of Ca into GSMCs (1.8-times, < 0.01). In terms of 5-HTR expression, circulatory contents of 5-HT and SP and Ca influx, AuCiBup demonstrated better prokinetic effects than AuCi. CONCLUSIONS: These findings indicate the potential for developing combination therapy with antidepressants and prokinetics in gastrointestinal dysmotility management.
背景:L(芸香科)(Au)和 Blanco(芸香科)(Ci)通常被用作双联促动力药,而 DC.(伞形科)(Bup)是传统中药中的一种草药抗抑郁药。
目的:本研究评估 Bup 与 Au 和 Ci 联合应用于多发性应激诱导的胃排空延迟(DGE)小鼠的协同促动力作用。
材料和方法:昆明小鼠分为对照组、DGE 组、AuCi 组和 AuCiBup 组。小鼠灌胃 AuCi(14.25g/kg)或 AuCiBup(22.13g/kg)提取物 12 天。检测胃排空率、肠动力比、蔗糖偏好和旷场试验,并测定血清 5-羟色胺(5-HT)、胃动素(MTL)、P 物质(SP)、5-HT 受体和 c-kit。测定原代培养胃平滑肌细胞(GSMCs)内 Ca 水平。
结果:AuCi 和 AuCiBup 治疗均显著降低胃残留率(39.5%和 67.7%, < 0.01)。治疗组血清 5-HT、MTL 和 SP 水平升高(AuCi:0.060mg/L,AuCiBup:0.089mg/L,DGE:0.025mg/L, < 0.01)。治疗后胃窦和十二指肠 5-HTR 和 c-kit 表达上调(AuCi 和 AuCiBup,分别为 DGE 的 4.3 倍和 2.8 倍, < 0.01)。AuCi 和 AuCiBup 的含药血清有效增加 GSMCs 内 Ca 内流(1.8 倍, < 0.01)。就 5-HTR 表达、循环 5-HT 和 SP 含量以及 Ca 内流而言,AuCiBup 显示出比 AuCi 更好的促动力作用。
结论:这些发现表明,在胃肠道动力障碍管理中,开发抗抑郁药和促动力药联合治疗的潜力。
Cancer Biother Radiopharm. 2023-3
Zhonghua Shao Shang Za Zhi. 2006-8
Chin J Integr Med. 2025-6
Neurogastroenterol Motil. 2021-4
Am Fam Physician. 2020-1-15
Neurogastroenterol Motil. 2019-10
Exp Physiol. 2019-5